Back

Clinical validity of single-gene non-invasive prenatal testing for sickle cell disease and beta thalassemia

2021-09-05 genetic and genomic medicine Title + abstract only
View on medRxiv
Show abstract

BackgroundSickle cell disease (SCD) and beta thalassemia ({beta}-thalassemia) are among the most common and severe genetically inherited disorders in the world. Although the maternal carrier status of these beta hemoglobinopathies is screened as a part of routine prenatal care in the US, the paternal carrier status is usually unavailable. Under this current screening paradigm, identification of the majority of SCD and beta thalassemia cases could therefore be delayed until newborn screening resu...

Predicted journal destinations